Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2010-11-15 Major Shareholding Noti…
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, Section 671B, which is a Notice of change of interests of a substantial holder. It details changes in voting power and relevant interests of a substantial shareholder in Cyclopharm Limited. This type of filing is a notification of major shareholding changes, not a financial report or management announcement. It does not contain financial statements or management discussion, nor is it an announcement of a report publication. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is a substantive notification rather than a brief announcement or certification.
2010-11-15 English
Half Yearly Report and Accounts 29 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D' and refers to a '30 June 2010 Half Year Report' for Cyclopharm Limited. It contains detailed financial data including revenues, losses, earnings per share, and operational updates for the half year ended 30 June 2010. The document includes comprehensive financial statements such as the Statement of Comprehensive Income, Statement of Financial Position, Cash Flows, and Notes to the Financial Statements. It also contains management commentary and auditor's review information. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2010
2010-08-30 English
Company Update 3 pages ?Kb
AGM Information Classification · 90% confidence The document is a company update from Cyclopharm Limited dated 6 July 2010. It references the recent AGM held in May 2010 and provides detailed information on strategic initiatives, operational updates, regulatory interactions (e.g., TGA inspection, FDA clinical trial), and business developments. The content is narrative and informative, focusing on progress and future plans rather than presenting financial statements or formal regulatory filings. It does not contain financial data or formal report content such as an Annual Report (10-K) or Interim Report (IR). It is not a transcript, audit report, or legal proceeding update. The document is longer than 5,000 characters and provides substantive company update information, but it is not a formal report or announcement of a report publication. Given the nature of the content as a company update following the AGM and discussing strategic progress, the best fitting category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting and related updates.
2010-07-05 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, including acquisition of shares by an indirect interest (wife of the director). The document is a formal notification of a director's personal share transactions, which fits the definition of 'Director's Dealing' filings. The document length is short and focused solely on this transaction, with no financial statements or broader company information. Therefore, the correct classification is Director's Dealing (DIRS).
2010-05-25 English
Regulatory Approval in China 2 pages ?Kb
Regulatory Filings
2010-05-24 English
2010 AGM Presentation - Audio Broadcast 2 pages ?Kb
AGM Information Classification · 100% confidence The document is titled 'AGM Presentation: Audio broadcast' and refers to an audio presentation by the Managing Director at the Annual General Meeting (AGM). It provides a link to listen to the presentation and background information about the company and its business. The content is clearly related to materials shared during an AGM event, specifically a presentation. The document length is 3615 characters, which is relatively short and consistent with a presentation announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2010-05-23 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.